Sage Therapeutics Inc
(FRA:SG7)
€
5.452
0.102 (1.91%)
Market Cap: 325.18 Mil
Enterprise Value: -211.07 Mil
PE Ratio: 0
PB Ratio: 0.61
GF Score: 49/100 SAGE Therapeutics Inc at Stifel Virtual Healthcare Conference Transcript
Nov 16, 2020 / 01:40PM GMT
Release Date Price:
€62.98
(-6.45%)
Paul Andrew Matteis
Stifel, Nicolaus & Company, Incorporated, Research Division - Co-Head of the Biotech Team, MD & Senior Analyst
Awesome. Great. Thanks, everyone, for joining us. Happy to be hosting this discussion with Sage Therapeutics' Chief Medical Officer, Steve Kanes; and the Chief Operating Officer, Mike Cloonan. Thank you guys for joining us virtually. Everyone's audio and video working well?
Michael Cloonan
Sage Therapeutics, Inc. - COO
Yes, Paul, we can hear you good. You can hear us?
Stephen J. Kanes
Sage Therapeutics, Inc. - Chief Medical Officer
Absolutely.
Paul Andrew Matteis
Stifel, Nicolaus & Company, Incorporated, Research Division - Co-Head of the Biotech Team, MD & Senior Analyst
Great. I appreciate you joining us outside by a lake. That's a beautiful scenery there.
Michael Cloonan;Paul Andrew Matteis
Sage Therapeutics, Inc. - COO;Stifel,
Exactly.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot